Brief: Vericel Announces FDA Approval Of Nexobrid
15/08/2024 21:58
Aug 15 (Reuters) - Vericel Corp VCEL.O :
* VERICEL ANNOUNCES FDA APPROVAL OF NEXOBRID FOR THE
TREATMENT OF
PEDIATRIC PATIENTS WITH SEVERE THERMAL BURNS
Source text for Eikon: ID:nGNX3SB6qf
Further company coverage: VCEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook